Research Article

A Prognostic Nomogram Based on Immune Scores Predicts Postoperative Survival for Patients with Hepatocellular Carcinoma

Table 1

Association between clinical pathological characteristics and immune scores in 299 hepatocellular carcinoma patients.

CharacteristicsImmune score
TotalLow (≤-786.8)Medium (-786.8 to -402.9)High (>-402.9)X2

Sample sizes29930 (10.03)61 (20.40)208 (69.57)
Sex1.3020.522
 Female8911 (36.67)20 (32.79)58 (27.88)
 Male21019 (63.33)41 (6.56)150 (72.12)
Age (years)17.2330.141
 ≤30133 (10.00)3 (4.92)7 (3.37)
 31-40161 (3.33)4 (6.56)11 (5.29)
 41-50363 (10.00)9 (14.75)24 (11.54)
 51-608811 (36.67)16 (26.23)61 (29.33)
 61-70998 (26.67)19 (31.15)72 (34.62)
 71-80442 (6.67)10 (16.39)32 (15.38)
 >8032 (6.67)0 (0.00)1 (0.48)
Grade8.5020.204
 1406 (20.00)5 (8.20)29 (13.94)
 21458 (26.67)33 (54.10)104 (50.00)
 310415 (50.00)20 (32.79)69 (33.17)
 4101 (3.33)3 (4.92)6 (2.88)
Stage11.5440.073
 I15110 (33.33)25 (40.98)116 (55.77)
 II728 (26.67)16 (26.23)48 (23.08)
 III7211 (36.67)20 (32.79)41 (19.71)
 IV41 (3.33)0 (0.00)3 (1.44)